Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2001-03-02
2011-11-15
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S450000, C424S489000, C424S490000, C424S502000
Reexamination Certificate
active
08057823
ABSTRACT:
The invention concerns nanocapsules, in particular with an average size less than 50 nm, consisting of an essentially lipid core liquid or semiliquid at room temperature, coated with an essentially lipid film solid at room temperature having a thickness of 2-10 nm. The invention also concerns a method for preparing same which consists in producing a reverse phase of an aqueous emulsion brought about by several temperature raising and lowering cycles. Said lipid nanocapsules are particularly designed for producing a medicine.
REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 5049322 (1991-09-01), Devissaguet et al.
patent: 5174930 (1992-12-01), Stainmesse et al.
patent: 5514670 (1996-05-01), Friedman et al.
patent: 5556617 (1996-09-01), Ribier et al.
patent: 5576016 (1996-11-01), Amselem et al.
patent: 5723137 (1998-03-01), Wahle et al.
patent: 5961970 (1999-10-01), Lowell et al.
patent: 5972389 (1999-10-01), Shell et al.
patent: 5993831 (1999-11-01), Ribier et al.
patent: 6066328 (2000-05-01), Ribier et al.
patent: 6121313 (2000-09-01), Gao et al.
patent: 6242099 (2001-06-01), Grandmontagne et al.
patent: 6245349 (2001-06-01), Yiv et al.
patent: 6248363 (2001-06-01), Patel et al.
patent: 2001/0010824 (2001-08-01), Handjani et al.
patent: 0 529 711 (1991-03-01), None
patent: 0 621 073 (1994-10-01), None
patent: 0 447 318 (1995-05-01), None
patent: 0 646 002 (1995-12-01), None
patent: 0 717 989 (1996-06-01), None
patent: 0 717 989 (1996-06-01), None
patent: WO91/07171 (1991-05-01), None
Magalhaes NS, et al: An Invitro kinetic exam and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride; J. Microencapsul. Mar.-Apr. 1995; 12(2): 195-205.
Aboubakar, M et al: Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained ny interfacial polymerization: J. Biomed Mater Res. Dec. 15, 1999; (4): 568-576.
Magalhaes et al, J. Microencapsul. Mar.-Apr. 1995; 12(2): 195-205.
Aboubaker et al, J. biomed Mater Res. Dec. 15, 1999; 47(4): 568-576.
Anton et al., “The universality of low-energy nano-emulsification,”International Journal of Pharmaceutics, vol. 377, pp. 142-147, 2009.
Anton et al., “Design and Production of nanoparticles formulated from nano-emulsion templates—A review,”Journal of Controlled Release, vol. 128, pp. 188-199, 2008.
Benoit Jean-Pierre
Heurtault Béatrice
Pech Brigitte
Proust Jacques-Emile
Richard Joël
Ethypharm S.A.
Foley & Lardner LLP
Hartley Michael G
Universite d'Angers
Young Micah-Paul
LandOfFree
Lipid nanocapsules, preparation process and use as medicine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipid nanocapsules, preparation process and use as medicine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipid nanocapsules, preparation process and use as medicine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4294048